Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1996 Feb;88(2):107–111.

Poorer prognosis in older patients with endometrial adenocarcinoma.

E Hernandez 1, D DeFilippis 1, K O'Connell 1, G Balsara 1, S Keyamanesh 1, L Anderson 1, P B Heller 1
PMCID: PMC2608017  PMID: 8776067

Abstract

It has been suggested that there are two types of endometrial carcinoma: the first arises in younger women who have hyperestrogenism and has a favorable prognosis and the second occurs in older women, is not associated to estrogen stimulation, and has a poorer prognosis. This study examined the hypothesis that more aggressive carcinomas are found in older patients with no evidence of estrogen stimulation. A retrospective review of all patients (N = 82) with endometrial carcinoma diagnosed and treated at our institution between 1978 and 1990 was undertaken. The following data were analyzed: age at diagnosis, stage, race, histologic type, grade, depth of myometrial invasion, absence or presence of associated hyperplasia, and survival. The mean age of the patients was 64.8 years. Sixty (73%) of the 82 patients were considered estrogen-positive either because of obesity (body mass index > or = 27.3) or the use of unopposed exogenous estrogen. There were no statistically significant differences between estrogen-positive and estrogen-negative patients. Patients > or = 65 years had a 5-year survival of 60% compared with 74% for younger patients. There was a trend toward higher histologic grade among the older patients. Otherwise no statistically significant differences were found between these two groups. Estrogen-negative women > or = 65 years had the worst prognosis with a 5-year survival of 29%. As identified by other investigators, age at diagnosis is a significant indicator of prognosis in patients with endometrial carcinoma. In this series, thin, older (> or = 65 years) women who developed endometrial carcinoma had the worst prognosis.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeler V. M., Kjørstad K. E. Endometrial adenocarcinoma in Norway. A study of a total population. Cancer. 1991 Jun 15;67(12):3093–3103. doi: 10.1002/1097-0142(19910615)67:12<3093::aid-cncr2820671226>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  2. Beckner M. E., Mori T., Silverberg S. G. Endometrial carcinoma: nontumor factors in prognosis. Int J Gynecol Pathol. 1985;4(2):131–145. [PubMed] [Google Scholar]
  3. Bokhman J. V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983 Feb;15(1):10–17. doi: 10.1016/0090-8258(83)90111-7. [DOI] [PubMed] [Google Scholar]
  4. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993 Jan-Feb;43(1):7–26. doi: 10.3322/canjclin.43.1.7. [DOI] [PubMed] [Google Scholar]
  5. Bucy G. S., Mendenhall W. M., Morgan L. S., Chafe W. E., Wilkinson E. J., Marcus R. B., Jr, Million R. R. Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors. Gynecol Oncol. 1989 Jun;33(3):290–295. doi: 10.1016/0090-8258(89)90514-3. [DOI] [PubMed] [Google Scholar]
  6. Davies J. L., Rosenshein N. B., Antunes C. M., Stolley P. D. A review of the risk factors for endometrial carcinoma. Obstet Gynecol Surv. 1981 Mar;36(3):107–116. doi: 10.1097/00006254-198103000-00001. [DOI] [PubMed] [Google Scholar]
  7. Elliott E. A., Matanoski G. M., Rosenshein N. B., Grumbine F. C., Diamond E. L. Body fat patterning in women with endometrial cancer. Gynecol Oncol. 1990 Dec;39(3):253–258. doi: 10.1016/0090-8258(90)90247-i. [DOI] [PubMed] [Google Scholar]
  8. Morrow C. P., Bundy B. N., Kurman R. J., Creasman W. T., Heller P., Homesley H. D., Graham J. E. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan;40(1):55–65. doi: 10.1016/0090-8258(91)90086-k. [DOI] [PubMed] [Google Scholar]
  9. Nyholm H. C., Nielsen A. L., Norup P. Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics. Gynecol Oncol. 1993 May;49(2):229–235. doi: 10.1006/gyno.1993.1112. [DOI] [PubMed] [Google Scholar]
  10. Silverberg S. G., Mullen D., Faraci J. A., Makowski E. L., Miller A., Finch J. L., Sutherland J. V. Endometrial carcinoma: clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving exogenous estrogens. Cancer. 1980 Jun 15;45(12):3018–3026. doi: 10.1002/1097-0142(19800615)45:12<3018::aid-cncr2820451224>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Smith M., McCartney A. J. Occult, high-risk endometrial cancer. Gynecol Oncol. 1985 Oct;22(2):154–161. doi: 10.1016/0090-8258(85)90021-6. [DOI] [PubMed] [Google Scholar]
  12. Underwood P. B., Jr, Miller M. C., Kreutner A., Jr, Joyner C. A., Lutz M. H. Endometrial carcinoma: the effect of estrogens. Gynecol Oncol. 1979 Aug;8(1):60–73. doi: 10.1016/0090-8258(79)90008-8. [DOI] [PubMed] [Google Scholar]
  13. Vardi J. R., Tadros G. H., Anselmo M. T., Rafla S. D. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet Gynecol. 1992 Aug;80(2):204–208. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES